MedDataX Logo

Novel Internet-Based Interventions to Reduce Sexual Risk Among Men Who Have Sex With Men

NCT ID: NCT00649701

Last Updated: 2008-06-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1

Total Enrollment

3097 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-04-30

Study Completion Date

2008-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to develop and test the efficacy of online HIV risk reduction interventions among men who have sex with men.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is an Internet-based, five-branch randomized controlled intervention, enrolling 3,000 adult MSM. The five branches include 1) a control condition receiving no intervention content, 2) a standard text-based prevention webpage, 3) an 8 minute dramatic video addressing sexual risk reduction within the context of alcohol use, 4) a 5 minute documentary video addressing HIV disclosure, HIV testing, and condom use with the sub-context of drug use, and 5) both videos. After completing the baseline survey, eligible participants who consent to participate in the intervention will be randomly assigned to the control condition or one of the four intervention conditions. The control condition will not include the delivery of any intervention content. All participants (branches 1-5) will be asked to complete a brief post-intervention survey (to measure intentions). All intervention participants will be invited to complete a final 60-day follow-up survey.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infections

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

HIV Internet MSM Condom Use Disclosure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Group Type NO_INTERVENTION

No interventions assigned to this group

2

Text-based webpage

Group Type EXPERIMENTAL

Standard Text-Based Prevention Web Page

Intervention Type BEHAVIORAL

A link to the CDC.gov web page which describes HIV prevention among men who have sex with men.

3

Talking about HIV video

Group Type EXPERIMENTAL

Talking About HIV

Intervention Type BEHAVIORAL

A documentary video addressing HIV disclosure, HIV testing, and condom use with the sub-context of drug use.

4

The Morning After video

Group Type EXPERIMENTAL

The Morning After

Intervention Type BEHAVIORAL

A dramatic video about 4 gay men addressing sexual risk reduction within the context of alcohol use.

5

Both videos

Group Type EXPERIMENTAL

Both Videos

Intervention Type BEHAVIORAL

Morning After and Talking About HIV videos

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard Text-Based Prevention Web Page

A link to the CDC.gov web page which describes HIV prevention among men who have sex with men.

Intervention Type BEHAVIORAL

The Morning After

A dramatic video about 4 gay men addressing sexual risk reduction within the context of alcohol use.

Intervention Type BEHAVIORAL

Talking About HIV

A documentary video addressing HIV disclosure, HIV testing, and condom use with the sub-context of drug use.

Intervention Type BEHAVIORAL

Both Videos

Morning After and Talking About HIV videos

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male;
* Age 18 and over;
* Ability to read and respond in English;
* Reside within the United States;
* Report oral or anal sex with any male (new partner or not) in the past 60 days AND report oral, anal or vaginal sex for the first time with any partner (male or female) in the past 60 days;
* Complete baseline survey
* Provide an email address;

Exclusion Criteria

* Women and transgender persons
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centers for Disease Control and Prevention

FED

Sponsor Role collaborator

Public Health Solutions

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Public Health Solutions

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sabina Hirshfield, PhD

Role: PRINCIPAL_INVESTIGATOR

Public Health Solutions

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Public Health Solutions

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Hirshfield S, Chiasson MA, Joseph H, Scheinmann R, Johnson WD, Remien RH, Shaw FS, Emmons R, Yu G, Margolis AD. An online randomized controlled trial evaluating HIV prevention digital media interventions for men who have sex with men. PLoS One. 2012;7(10):e46252. doi: 10.1371/journal.pone.0046252. Epub 2012 Oct 2.

Reference Type DERIVED
PMID: 23071551 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CDC-URS PS000415

Identifier Type: -

Identifier Source: org_study_id